PBSS Workshop – Small Molecule Preclinical Development and IND Filing: Nuts, Bolts and Best Practices

  • Apr 30
  • Location: Hilton San Diego/Del Mar, Del Mar, CA
  • Workshop

Happy Hour Sponsor & Vendor

Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives, expectations, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward. Often, there are cases where too many nice-to-have studies crowd in the package but critical studies/issues are not addressed, and this can lead to significant delays in clinical development. Additionally, the regulatory environment is changing as rapidly as the industry. Therefore, keeping up to date on the regulatory requirements and the industry’s best practices in different aspects including non-clinical safety, PK, CMC, and clinical plan is paramount.

Below are the topics to be covered:

  • Overview of preclinical development and IND filing for small molecules
  • Key preclinical studies required (Safety, DMPK & CMC)
  • Clinical Development plans
  • Regulatory strategies
  • Interacting with regulatory agencies

Use the contact form below to meet with an Alturas representative in San Diego!

"*" indicates required fields